H. Lundbeck A/S
↗Valby, Copenhagen, Denmark
Lundbeck is a global pharmaceutical company headquartered in Copenhagen, Denmark, that specializes exclusively in brain diseases. For over 70 years, the company has focused on the research, development, and commercialization of therapies for psychiatric and neurological disorders, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, and epilepsy.
The company operates with a strong commitment to neuroscience, maintaining a full-value-chain R&D center and production facilities in Denmark, with additional research and development centers in the United States and Asia. Lundbeck is majority-owned by the Lundbeck Foundation, which supports medical research and educational activities, and it is listed on the Nasdaq Copenhagen stock exchange.
CLASSIFICATION
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$3.72B
Founded:1915
Ownership:public
Status:operating
FUNDING
Investors:The Lundbeck Foundation
STOCK
Exchange:Nasdaq Copenhagen
Ticker:LUN
Market Cap:$6.41B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, mAb
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Longboard Pharmaceuticals
Key Partnerships:Otsuka Pharmaceutical (collaboration on Rexulti and other CNS assets)
COMPETITION
Position:Leader
Competitors:Jazz Pharmaceuticals, Sana Biotechnology, C4 Therapeutics, UCB
LEADERSHIP
Key Executives:
Charl van Zyl - President & CEO
Joerg Hornstein - CFO
Johan Luthman - EVP, Head of R&D
LINKS
Website:lundbeck.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of H. Lundbeck A/S and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with H. Lundbeck A/S. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.